inancing supports ongoing clinical operations, development, and commercialization preparation HALIFAX, NS, Oct. 14, 2025 /PRNewswire/ – ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, today announced an oversubscribed US$35 million Series D financing. The round was led by new investor, J.P. Morgan Life […]



